Quinazolines

Results: 237



#Item
31Microsoft Word - 14A002-TAR-WPI.doc

Microsoft Word - 14A002-TAR-WPI.doc

Add to Reading List

Source URL: www.us.astellas.com

Language: English - Date: 2015-05-01 11:57:22
32continuing education Disclosure of Conflicts of Interest The Nurse Practitioner Healthcare Foundation (NPHF) assesses conflict of interest with its instructors, planners, reviewers, and other individuals who are in a pos

continuing education Disclosure of Conflicts of Interest The Nurse Practitioner Healthcare Foundation (NPHF) assesses conflict of interest with its instructors, planners, reviewers, and other individuals who are in a pos

Add to Reading List

Source URL: www.nphealthcarefoundation.org

Language: English - Date: 2013-10-17 16:34:03
33HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TARCEVA safely and effectively. See full prescribing information for TARCEVA. TARCEVA® (erlotinib) tablets, oral In

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TARCEVA safely and effectively. See full prescribing information for TARCEVA. TARCEVA® (erlotinib) tablets, oral In

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2012-04-20 13:17:56
34Therapeutic control and resistance of the EGFR-driven signaling network in glioblastoma

Therapeutic control and resistance of the EGFR-driven signaling network in glioblastoma

Add to Reading List

Source URL: www.biosignaling.com

Language: English
35

PDF Document

Add to Reading List

Source URL: www.mirg.org

Language: English - Date: 2010-10-19 13:00:54
36technology offer A Cobalt-Based Strategy for Tumour Targeting by EGFR-Inhibitors Background The development of receptor tyrosine-kinase inhibitors (TKIs) in recent decades was a major step forward in cancer treatment. Ho

technology offer A Cobalt-Based Strategy for Tumour Targeting by EGFR-Inhibitors Background The development of receptor tyrosine-kinase inhibitors (TKIs) in recent decades was a major step forward in cancer treatment. Ho

Add to Reading List

Source URL: forschung.univie.ac.at

Language: English - Date: 2014-04-23 07:44:21
37Microsoft Word - Art 45 UK_W_0077_pdWSfinal PAR.docx

Microsoft Word - Art 45 UK_W_0077_pdWSfinal PAR.docx

Add to Reading List

Source URL: www.hma.eu

Language: English - Date: 2015-03-10 11:29:41
38Lung cancer / Amines / Quinazolines / Alkynes / Erlotinib / Ethers / Epidermal growth factor receptor / Protein kinase inhibitor / Targeted therapy / Chemistry / Organic chemistry / Medicine

DOCX Document

Add to Reading List

Source URL: www.pbs.gov.au

Language: English - Date: 2015-03-23 21:11:42
39Impact of ABCG2 polymorphisms on the clinical outcome of TKIs therapy in Chinese advanced non-small-cell lung cancer patients

Impact of ABCG2 polymorphisms on the clinical outcome of TKIs therapy in Chinese advanced non-small-cell lung cancer patients

Add to Reading List

Source URL: www.cancerci.com

Language: English
40Pharmacogenomics of EGFR-targeted therapies in nonŁsmall cell lung cancer: EGFR and beyond

Pharmacogenomics of EGFR-targeted therapies in nonŁsmall cell lung cancer: EGFR and beyond

Add to Reading List

Source URL: www.cjcjournal.com

Language: English